0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Kathleen Stergiopoulos, MD, PhD; David L. Brown, MD
JAMA Intern Med. 2014;174(8):1330-1338. doi:10.1001/jamainternmed.2014.2368.
Includes: Supplemental Content

Invited Commentary | 
Dhruv S. Kazi, MD, MSc, MS; Mark A. Hlatky, MD
JAMA Intern Med. 2014;174(8):1338-1339. doi:10.1001/jamainternmed.2014.1227.

Evidence to Practice | 
Daniel A. Ollendorf, MPH; Jeffrey A. Tice, MD; Steven D. Pearson, MD, MSc
JAMA Intern Med. 2014;174(7):1170-1171. doi:10.1001/jamainternmed.2014.2151.

Special Article | 
Geoffrey S. Ginsburg, MD, PhD; Richard P. Konstance, MD; Jennifer S. Allsbrook, BSPH; et al.
Arch Intern Med. 2005;165(20):2331-2336. doi:10.1001/archinte.165.20.2331.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Viewpoint  | 
Genomics-Enabled Drug Repositioning and Repurposing:  Insights From an IOM Roundtable Activity
Aidan Power, MB, BCh, MRC Psych; Adam C. Berger, PhD; Geoffrey S. Ginsburg, MD, PhD
JAMA Dermatology
Observation  | 
Spindle Cell Squamous Carcinoma During BRAF Inhibitor Therapy for Advanced Melanoma:  An Aggressive Secondary Neoplasm of Undetermined Biologic Potential
Daniel N. Cohen, MD, PhD; Wilfred A. Lumbang, MD; Alan S. Boyd, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
VEGFA and VEGFR2 Gene Polymorphisms and Response to Anti–Vascular Endothelial Growth Factor Therapy:  Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
Stephanie A. Hagstrom, PhD; Gui-shuang Ying, PhD; Gayle J. T. Pauer, BA; et al.
JAMA
Health Agencies Update  | 
Public-Private Groups Seek Drug Targets
Bridget M. Kuehn, MSJ